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Abstract
Superparamagnetic Iron Oxide (SPIO) complexed with cationic transfection agent is used to label various mammalian cells.
Labeled cells can then be utilized as an in vivo magnetic resonance imaging (MRI) probes. However, certain number of in
vivo administered labeled cells may be cleared from tissues by the host’s macrophages. For successful translation to routine
clinical application of SPIO labeling method it is important that this mode of in vivo clearance of iron does not elicit any
diverse immunological effects. The purpose of this study was to demonstrate that SPIO agent ferumoxides-protamine
sulfate (FePro) incorporation into macrophages does not alter immunological properties of these cells with regard to
differentiation, chemotaxis, and ability to respond to the activation stimuli and to modulate T cell response. We used THP-1
cell line as a model for studying macrophage cell type. THP-1 cells were magnetically labeled with FePro, differentiated with
100 nM of phorbol ester, 12-Myristate-13-acetate (TPA) and stimulated with 100 ng/ml of LPS. The results showed 1) FePro
labeling had no effect on the changes in morphology and expression of cell surface proteins associated with TPA induced
differentiation; 2) FePro labeled cells responded to LPS with slightly higher levels of NFkB pathway activation, as shown by
immunobloting; TNF-a secretion and cell surface expression levels of CD54 and CD83 activation markers, under these
conditions, were still comparable to the levels observed in non-labeled cells; 3) FePro labeling exhibited differential,
chemokine dependent, effect on THP-1 chemotaxis with a decrease in cell directional migration to MCP-1; 4) FePro labeling
did not affect the ability of THP-1 cells to down-regulate T cell expression of CD4 and CD8 and to induce T cell proliferation.
Our study demonstrated that intracellular incorporation of FePro complexes does not alter overall immunological properties
of THP-1 cells. The described experiments provide the model for studying the effects of in vivo clearance of iron particles via
incorporation into the host’s macrophages that may follow after in vivo application of any type of magnetically labeled
mammalian cells. To better mimic the complex in vivo scenario, this model may be further exploited by introducing
additional cellular and biological, immunologically relevant, components.
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Introduction
Over the recent years imaging techniques that enable efficient
and non-invasive in vivo monitoring and trafficking of transplanted
cells have become central to the successful development of cell
transplantation based diagnostic and therapeutic approaches.
Currently, a number of imaging modalities, such as positron
emission tomography (PET), single photon emission-computed
tomography (SPECT) and magnetic resonance imaging (MRI) are
being perfected for the purpose of in vivo cell tracking.
Nevertheless, translation to routine clinical application of such
methods strongly depends on the availability of efficient cell
labeling reagent that does not exhibit toxic effect in labeled cell,
enables successful detection by chosen imaging technique and
most importantly, does not elicit side effects in human recipients.
One of the contrast agents used with MRI imaging technique is
superparamagnetic iron oxide (SPIO). SPIO has been in use as an
intravenous MRI contrast agent for analyzing the liver pathology
[1], but also as an ex vivo cell labeling agent for various types of
mammalian cells that when labeled can be utilized as an in vivo
MRI probes. For example, SPIO has been successfully used for the
labeling of cancer cells [2], T cells [3], dendritic cells [4] and stem
cells [5,6]. As reported before, SPIO labeling does not exhibit
adverse effects on cell physiology [7] and when combined with
cationic transfection reagents, is relatively stably incorporated
within the endosomal cellular compartment [8]. Regardless of the
mode of in vivo SPIO administration, intravenously or within the
labeled cells, its application is coupled with time dependent change
in the MRI signal intensity due to the in vivo dilution of
administered iron that is attributed to the clearance of iron by
host immune cells. When administered intravenously as free
circulating SPIO nanoparticles, most of the nanoparticles are
cleared by the resident phagocytic cells in liver (Kupffer cells) and
spleen (splenic macrophages) [1,9]. When administered as
intracellularly incorporated iron particles, the most probable
mode of SPIO release into the extracellular space is exocytosis that
may be coupled with cell division [10]. The released SPIO
particles may ultimately be cleared from tissues by resident/tissue
macrophages. In addition, certain number of in vivo administered
labeled cells undergoes apoptosis and these dead cells may also be
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load on the functional properties of host macrophage system has
not been studied before. For successful clinical application of SPIO
labeling method it is important that this mode of in vivo clearance
of iron or FePro labeled cells does not elicit any diverse
immunological effects.
Previously, we have reported a novel method for generating
magnetically labeled cells that is based on combining Ferumoxides
(Fe) and Protamine Sulfate (Pro) into Superparamagnetic Iron
Oxide (SPIO)-transfection agent complex (FePro) [6,11]. Ferum-
oxide is a suspension of dextran coated SPIO particles that has
been approved by US Food and Drug Administration (FDA) as an
in vivo MRI contrast reagent for the use in humans. Protamine
Sulfate is a polycationic agent (also approved by FDA for clinical
use) that when combined with Fe enables efficient and effective
intracellular incorporation of SPIO particles. In this study we
utilized THP-1 cell line to demonstrate that FePro incorporation
into macrophages does not alter immunological properties of these
cells. THP-1 cells, a human monocytic cell line, were derived from
the patient with acute monocytic leukemia. THP-1 cells were
described to have characteristics of monocyte cell type and upon
stimulation with reagents such as phorbol esters or 1,25 dihydroxy
vitamin D3, can be differentiated into immunologically active cells,
i.e. macrophages [12]. THP-1 cell line has been extensively
characterized [13,14,15] and widely used as a model for studying
macrophage cell type [16,17,18]. In addition, due to the good
labeling efficiency and reproducibility, THP-1 cells have very often
been a cell type of choice for characterizing the SPIO labeling
agents [19,20]. We hypothesize that FePro labeling will not affect
the physiological ability of THP-1 cells to maintain non-
differentiated state nor it will affect their ability to respond to
the activation stimuli and to modulate T cells response.
Materials and Methods
Cell culture
THP-1 cells (ATCC, Rockville, MD) were maintained in RPMI
1640 (Sigma, St. Louis, MO) supplemented with 10% heat
inactivated Fetal Calf Serum (Hyclone) and 0.05 mM 2-mercap-
toethanol (Chemicon), as recommended by ATCC. For each
experiment cells were labeled with Fe-Pro (described in detail in
the section bellow), incubated for 24 h in the presence of 100 nM
of phorbol ester, 12-Myristate-13-acetate (TPA) (Cell Signaling
Tecnology) to induce differentiation. Following the differentiation,
cells were stimulated for 30 min or 4 h with 100 ng/ml of
Escherichia coli lipopolysaccharide (LPS).
Cell labeling
THP-1 cells were labeled with ferumoxides-protamine sulfate
complex (Fe-Pro) according to our previously reported method
[6,11]. In brief, FePro was generated by mixing the commercially
available ferumoxides (Feridex IV; Berlex Laboratories, Wayne,
NJ, USA) and protamine sulfate (American Pharmaceuticals
Partners, Shaumburg, IL, USA). Protamine sulfate supplied as
10 mg/ml of stock solution was freshly diluted to a concentration
of 1 mg/ml in distilled water at the time of use. Ferumoxides was
suspended in RPMI 1640 medium (Mediatech, Herndon, VA,
USA) supplemented with MEM nonessential amino acids and
sodium pyruvate, at the concentration of 100 mg/ml. Protamine
sulfate was then added to the ferumoxide suspension to the final
concentration of 4.5 mg/ml. Ferumoxides and protamine sulfate
mixture was intermittently mixed for about a minute to generate
Fe-Pro complex. THP-1 cells were washed once and suspended at
the concentration of 4610
6 cell/ml in RPMI containing the Fe-
Pro complex, and incubated for 2 hours within the 6-well culture
plates at 37uC, in 5%CO2 humidified atmosphere. After 2 hours
of incubation complete THP-1 media was added to adjust the
concentration of cells and Fe-Pro to the following: 2610
6 cells/ml
for THP-1 cells, 50 mg/ml for ferumoxides/mL and 2.25 mg/ml
for protamine sulfate. After overnight incubation at 37uCi n
5%CO2 humidified atmosphere, cells were washed three times
with 16PBS to eliminate extracellular Fe-Pro complexes and used
for the experiments.
Staining for intracellular iron and determining the
labeling efficiency
Aliquots of labeled and non-labeled control THP-1 cells were
transferred to glass slides and fixed with 4% paraformaldehyde.
Prussian blue cellular staining was performed by incubating fixed
cells in a mixture of 4% potassium ferrocyanide and 3.7%
hydrochloric acid (Perl reagent for Prussian blue staining) for
30 minutes. Slides were then washed and cells counterstained with
nuclear fast red. The cells were evaluated by light microscopy to
asses the labeling efficiency. Cells exhibiting blue intracellular
particles were considered Prussian-blue positive. The percentage of
labeled cells was determined from the average of the labeled cells to
the total number of cells from four randomly selected fields of view.
Intracellular Iron Quantification
Quantification of intracellular iron in THP-1 labeled cells was
performed as previously described [11,21]. Briefly, after labeling
with FePro, the cells were washed three times with 16PBS to dispose
of extracellular FePro. Triplicates of labeled and non-labeled THP-1
cells (2610
5 cells per tube) were centrifuged at 3000 rpm for
5 minutes. After discarding the supernatants, cell pellets were
incubated at 110uC overnight (no cap on tubes). The next day, iron
was dissolved by adding 1 mL of 5 M hydrochloricacidto eachtube
and samples were further incubated at 60uCf o r4h .D u r i n gt h i s
incubation step, tubes were capped to prevent acid evaporation.
Then, 0.5 ml of acid solution from each tube was transferred to a
separate 1.5 ml cuvette and absorbance was read at 351 nm. The
average absorbance value for each sample (3 tubes for each sample)
was divided by the number of cells to determine the average iron
concentration per cell. Iron concentration was determined using the
standard curve obtained by plotting the known iron concentration of
several dilutions of iron vs. absorbance.
TNF-a protein secretion – ELISA
After labeling with Fe-Pro complex, THP-1 cells were
suspended in complete THP-1 cell media at the concentration of
1610
6 cells/ml and differentiated for 24 h in the presence of
100 nM of TPA (at 37uCi n5 %C O 2). After cell differentiation,
culture media was replaced and cells were incubated for additional
4 hours in the presence of 100 ng/ml of LPS. After LPS
stimulation, THP-1 cell supernatants were collected and analyzed
for the levels of secreted TNF-a protein by ELISA MAX
TM Set
Deluxe kit (BioLegend) according to the manufacturer’s instruc-
tions. Reference curve for each experiment was obtained by
plotting the TNF-a concentration of several dilutions of standard
protein vs. absorbance.
Nuclear and cytoplasmic protein extraction
Nuclear and cytoplasmic protein extracts were prepared using the
Nuclear Extraction Kit (Active Motif, Carlsbad, CA) according to
the manufacturer’s instructions. In brief, cell pellets were re-
suspended in 16 Hypotonic Buffer (Active Motif), and incubated
on ice for 15 minutes. Detergent was then added and the suspension
FePro Labeled Macrophage
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cooled to 4uC. Supernatants containing the cytoplasmic protein
fraction were collected, while the nuclear pellets were re-suspended
in Complete Lysis Buffer (Active Motif), vortexed for 10 seconds and
incubated 30 minutes on ice on a rocking platform at 150 rpm;
vortexed for 30 seconds at the highest setting and centrifuged for
10 minutes at 14,0006g ina microcentrifugepre-cooledto 4uC.The
nuclear fractions were collected into a pre-chilled microcentrifuge
tubes. Protein concentration was determined with Bio-Rad Protein
Assay (Bio-Rad Laboratories, Hercules, CA), using Bovine Serum
Albumin (BSA) as a standard.
Western blot - NFkB and IkB expression analysis
Five mg of nuclear protein and 10 mg of cytoplasmic protein
were resolved on 10% SDS polyacrylamide gels, transferred to
nitrocellulose membrane (BioRad) and probed overnight at 4uC
with specific primary antibodies: mouse monoclonal IgG3 for p65
subunit of NF-kB (MAB3026) (Chemicon International) at the
concentration of 5 mg/ml and 1:500 dilution of rabbit polyclonal
IgG for IkBa (624901) (Biolegend). Primary antibody binding was
detected by incubating the membrane in the presence of
horseradish peroxidase (HRP) conjugated secondary polyclonal
donkey antibody with specificity for rabbit IgG or polyclonal sheep
antibody with specificity for mouse IgG (both from GE Healthcare
Lifesciences) for 1 h at room temperature. The signal was detected
by enhanced chemiluminescence using the ECL Detection Kit
(GE Healthcare Lifesciences).
THP-1 cell migration assay
Rantes and Monocyte Chemotactic Protein-1(MCP-1) induced
THP-1 cell directional migration was analyzed using QCM
TM
Chemotaxis 5 mm 96-well Cell Migration Assay kit (Chemicon)
according to the supplier’s experimental protocol. In brief, THP-1
cells were labeled with Fe-Pro and differentiated for 24 h with TPA,
as described. After differentiation, cells were resuspended in serum
free RPMI at the concentration of 2610
6 cell/ml and 100 mlo fc e l l
suspension was placed into migration chamber of QCM
TM
Chemotaxis Plate Assembly (Chemicon). Recombinant human
Rantes and MCP-1 (BioLegend, San Diego, CA) were diluted in
serum free RPMI to final concentrations of 50 and 300 ng/ml,
respectively. Total of 150 ml of this solution was placed into the wells
of the bottom, i.e. feeder tray. As suggested by manufacturer and as
described before [22], in parallel experiment 150 ml of RPMI
containing 10% FBS was loaded into the wellsof the feeder tray,as a
positive control. Chemotaxis plate was then re-assembled and
incubatedat37uCin5%CO 2for4 hourstoallowforTHP-1cellsto
migrate from the top to the bottom chambers through 5 mms i z e
pores. After incubation, 75 ml of suspension containing cells that
migrated was transferred from migration feeder tray to the well of a
new 96-well plate; while the migrated cells that were still attached to
the bottom side of the migration chamber filter were dislodged by
incubating in Cell Detachment Solution (Chemicon) for 30 minutes
(37uCin5%CO 2).Seventyfive ml ofdislodgedcells were mixed with
thecellsthatwerepreviouslycollectedfromthemigrationfeedertray
and incubated for 15 minutes with 50 ml of Lysis Buffer/Dye
Solution (Chemicon) after which fluorescence was read using 480/
520 filter set.
THP-1 cell co-culture with T cells - CD4 and CD8
expression and THP-1 induced allogeneic T cell
proliferation
To determine the effect of Fe-Pro labeling on THP-1 cells’ ability
to modulate T cells with regard to CD4 and CD8 expression and
proliferation, co-culture was set up with the THP-1 cells/T cell ratio
of 1:10. T-cells were isolated the previous day from human cord
blood, with an IRB approved protocol, by Ficoll gradient
centrifugation followed by immunomagnetic CD3
+ selection using
MACSH system (Miltenyi Biotec Inc, Auburn, CA) according to the
protocol supplied by the manufacturer. Isolated CD3
+ cells were
cultured in the presence of IL-2 cytokine (10 ng/ml) for 24 h, after
which cells were analyzed by flow cytometry for the expression of
CD3 and used in co-culture experiments. For the analysis of CD4
and CD8 expression on T cells, FePro labeled THP-1 cells were
differentiated in the presence of 100 nM of TPA for 24 h in 24-well
culture plates (5610
5 cells per well). After differentiation, THP-1
cells werestimulated with 100 ng/mlof LPS for 4 hours,after which
media was replaced with the fresh media containing CD3
+ Tc e l l s .
THP-1 cells were co-cultured with CD3
+ T-cells for 24 h at 37uCi n
5% CO2. After 24 h of co-culture, cells were analyzed by flow
cytometry for the expression of cell surface CD4, CD8 and CD3
markers. For the analysis cells were gated based on forward angle
light scatter (FSC) and side angle light scatter (SSC) characteristics
(R1)and theexpression of CD3 marker (R2).Toanalyze theeffectof
FePro labeled THP-1 cells on T cell proliferative activity, TPA
differentiated and c-irradiated (20 Gy) THP-1 cells were co-cultured
with T cells (1:10 ratio). After 3 and 7 days of co-culture T cell
proliferation was analyzed by performing MTT (3-[4,5-di-
methylthiazol-2-yl] -2,5-diphenyl tetrazolium bromide) assay (Roche
Molecular Biochemicals) according to the protocol supplied by the
manufacturer. The absorbance of the formazan product was
measured at a wavelength of 570 nm with 750 nm (subtracted) as
reference.
Flow cytometry
Fe-Pro labeled THP-1 cells were differentiated for 24 h in the
presence of 100 nM of TPA and stimulated for 4 h with 100 ng/
ml of E.coli LPS. Cells were washed in ice cold 16 PBS and
incubated for 309 on ice, in dark, with the respective fluorescently
labeled antibodies. Fluorescence activated flow cytometry was
performed with LSR II (Becton Dickinson) flow cytometer and a
minimum of 10,000 events were analyzed for each sample. Live
cells used for the analysis, were gated based on forward angle light
scatter (FSC) and side angle light scatter (SSC) and further
analyzed using the Cell Quest Pro software (Becton Dickinson).
Specific antibodies that were used in flow cytometric experi-
ments to analyze the expression of cell surface markers were: FITC
conjugated mouse anti-human CD3 IgG2b (Biolegend), PE
conjugated mouse anti-human CD8 IgG1 (Biolegend), PE/Cy5
conjugated mouse anti-human CD4 IgG1 (Biolegend), PE
conjugated mouse anti-human CD117 IgG1 (Biolegend), PE
conjugated mouse anti-human CD54 IgG2a (Biolegend), FITC
conjugated mouse anti-human CD11b IgG1 (Biolegend), PE/Cy5
conjugated mouse anti-human CD86 IgG2b (Biolegend), PE
conjugated mouse anti-human CD83 IgG1 (BD Biscience), PE/
Cy5 conjugated mouse anti-human HLA-DR IgG2a (Biolegend)
and FITC conjugated mouse anti-human CD195 IgG2a (Biole-
gend). All the antibodies were used in the concentrations suggested
by the suppliers.
Statistical analysis
Each experiment was performed at least two times and each
sample was tested in triplicate. Data are expressed as mean6SD.
Statistically significant difference was determined by performing
one way ANOVA analysis followed by Fisher’s PLSD post-hoc
test, when the there were more than two groups. For analysis
between two groups student-t test was used. A value of p,0.05 was
considered significant.
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Effect of Fe-Pro labeling on THP-1 cells ability to
differentiate in response to TPA
Labeling procedure and cellular incorporation of FePro
complexes did not affect the ability of THP-1 cells to differentiate
towards macrophage cell type. To confirm the FePro cellular
uptake, THP-1 cells were stained with Prussian blue. Represen-
tative bright light photomicrographs of FePro labeled THP-1 cells
are shown in Figure 1. Labeled THP-1 cells exhibited abundant
heterogeneous uptake of FePro complexes that typically appears as
blue granules inside the cytoplasm. Labeling efficiency analysis
revealed that more than 95% of the cells were positive for Prussian
blue. Quantitative analysis of intracellular iron concentration
confirmed the microscopically observed THP-1 cell iron internal-
ization. Iron labeled THP-1 cells contained an average of 8.2+0.30
pg iron/cell, versus 0.36+0.01 pg iron/cell in non-labeled THP-1
cells.
After stimulation with 100 nM of TPA for 24 h, THP-1 cells
underwent morphological changes that indicated differentiation
towards macrophage cell type. As confirmed by phase contrast
microscopy, through the process of differentiation monocyte like
THP-1 cells changed from non-adherent, suspension cells to the
macrophage like cells that exhibited cell adhesion, spreading,
increased granularity and attachment to the bottom of the culture
plates. There was no difference in the morphological appearance
between FePro labeled and non-labeled THP-1 cells before or
after TPA induced differentiation (Figure 2).
In addition to the morphological changes, differentiation
process is associated with phenotypical changes that include
changes in expression of specific cell surface proteins that play
important roles in regulating immunological competence of
macrophage type cells. To determine whether intracellular FePro
incorporation affected the ability of THP-1 cells to upregulate cell
surface proteins in response to TPA stimulation, we analyzed the
levels of CD11b, CD117, HLA-DR and CD86 cell surface
differentiation markers in FePro labeled and non-labeled THP-1
cells. No significant differences in the levels of CD11b, CD117,
HLA-DR and CD86 expression between FePro labeled and non-
labeled THP-1 cells were observed, as determined by flow
cytometric analysis at 24 h of incubation in the presence of
100 nM of TPA (Figure 3).
Effect of Fe-Pro labeling on THP-1 cells ability to respond
to LPS stimulation
One of the best described macrophage activators commonly
released by Gram-negative bacteria during the course of infection
is LPS. To assess the ability of FePro labeled THP-1 cells to
respond to LPS stimulation we have analyzed the effect of LPS on
the expression levels of cell surface CD54 and CD83 activation
markers, TNF-a secretion and activation of intracellular NFkB
signaling pathway.
Flow cytometric analysis of FePro labeled and non-labeled, TPA
differentiated THP-1 cells showed that LPS stimulation increased
the level of CD54 and CD83 expression in THP-1 cells. The levels
of upregulated protein expression were comparable in FePro
labeled and non-labeled cells (Figure 4A). In addition to the LPS
induced changes at the THP-1 cell surface, we have also analyzed
the effect of LPS on TNF-a cytokine expression. As determined by
ELISA, after 24 h of TPA (100 nM) induced differentiation and
4 h of stimulation with 100 ng/ ml of LPS, no difference was
observed (p.0.05) between non-labeled and FePro-labeled THP-1
cells in the levels of secreted TNF-a protein (Figure 4B).
Most of the biological effects of LPS on macrophage type cells
have been extensively characterized and are achieved through the
activation of NFkB cell signaling pathway [23]. Stimulation of this
pathway results in the phosphorylation of cytoplasmic IkBa which
then dissociates from NFkB enabling it to translocate to the
nucleus and facilitate gene transcription. Dissociated IkBa is
subsequently degraded and that results in a decrease of
cytoplasmic IkBa levels. It has been shown that TNF-a as well
as CD54 expression is regulated by NFkB [24]. To determine the
effect of FePro labeling on NFkB signaling pathway we have
performed Western blot analysis of cytoplasmic and nuclear
protein fractions extracted from TPA differentiated THP-1 cells
that were stimulated with 100 ng/ ml of LPS for 30 minutes.
Immunobloting of the nuclear protein extract showed that FePro
labeled as well as non-labeled cells up-regulated the levels of
Figure 1. Prussian blue staining of FePro labeled THP-1 cells.
THP-1 cells were labeled overnight with ferumoxide-protamine sulfate
complex and stained using Prussian blue method to visualize the
intracellular iron incorporation (A). Non-stained THP-1 cells were used
as a negative control (B).
doi:10.1371/journal.pone.0002499.g001
Figure 2. Effect of FePro labeling on THP-1 cell differentiation.
THP-1 cells were labeled with FePro complexes and then differentiated
in the presence of 100 nM of TPA for 24 h. Phase contrast
photomicrograhs of non-labeled THP-1 cells before (A) and 24 h after
incubation with 100 nM of TPA (B). FePro labeled THP-1 cell before (C)
and 24 h after incubation with 100 nM of TPA (D).
doi:10.1371/journal.pone.0002499.g002
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further increased upon the stimulation with LPS. It appeared that
FePro labeled calls responded with slightly higher levels of nuclear
p65 NFkB, as compared to the same in non-labeled cells
(Figure 4C, top panel) and the same pattern of relative p65 NFkB
expression were observed in repeated experiments (n=3).
However, this difference did not translate into discrepancies at
the protein (TNF-a and CD54) levels between FePro labeled and
non-labeled cells. As anticipated, parallel changes were observed
in cytoplasm with regard to the levels of IkBa protein, i.e. TPA
induced a decrease that was further potentiated with LPS
stimulation. The observed decrease in IkBa expression levels was
comparable in FePro labeled and non-labeled THP-1 cells and the
same patterns of IkBa relative expression were seen in three
separate experiments (Figure 4C, bottom panel).
Effect of FePro labeling on THP-1 cells chemotaxis
One of the important characteristics of the cells of macrophage/
monocytic lineage is the ability to exhibit directional migration, i.e.
chemotaxis, along the concentration gradients of biologically active,
low molecular weight peptides called chemokines. Therefore we
analyzed the effect of FePro labeling on THP-1 cells chemotaxis by
determining their ability to migrate along the concentration
gradients of MCP-1 and Rantes chemokines. When incubated for
4 h in the presence of MCP-1, FePro labeled THP-1 cells migrated
insignificantlysmallernumberscomparedtothenon-labeledcontrol
cells (Figure 5A). Furthermore, this decrease in ability of FePro
labeled cells to migrate was also observed when cells were incubated
in the presence of 10% FBS. On the other hand, responsiveness of
THP-1 cells to Rantes was not significantly affected by FePro
labeling as no difference was observed between FePro labeled and
non-labeled THP-1 cells (Figure 5B). These data indicate that FePro
labeling may cause an overall decrease in THP-1 chemotaxis.
However, it is possible that an unknown mechanism may be in place
thatenables the maintenanceofchemotaxistowards Rantesafterthe
FePro labeling.
Effect of FePro labeling on THP-1 cells ability to modulate
T cell function
As part of the ‘‘first line of defense’’ macrophages play a crucial
role in innate immunity. However, as antigen presenting cells
macrophages have an important function in adaptive immunity as
well. One of the aspects of macrophage role in modulating
adaptive immune response is the interaction with T cells.
Therefore, we have analyzed the effect of FePro labeling on the
THP-1 cells ability to modulate allogeneic CD3
+ T cells by
analyzing T cell surface expression of CD4 and CD8, and T cell
proliferative activity. After 24 h hours of co-culturing T cells with
Figure 3. Effect of FePro labeling on the THP-1 cells expression of differentiation induced cell surface markers. The data depicts the
levels of protein expression in non-labeled (A) and FePro labeled THP-1 cells (B) after 24 h incubation with 100 nM of TPA and following 4 h
incubation with 100 ng/ml of LPS. After incubation, cells were stained with FITC conjugated anti-CD11b, PE conjugated anti-CD117 and PE-Cy5
conjugated anti-HLA DR and anti- CD86. Flow cytometric histograms of the non treated (control) cells (solid green lines), TPA treated (solid blue lines)
and TPA and LPS treated (solid yellow lines) from one representative experiment are shown (n=3). At least 10,000 live-gated cells were analyzed for
FITC, PE or PE-Cy5 expression. Isotype control shown as solid blue histograms.
doi:10.1371/journal.pone.0002499.g003
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was observed, as compared to CD4 expression in control T cells
(cells cultured without THP-1 cells). Detected CD4 expression in
T cells co-cultured with THP-1 cells was lower then the basal
expression observed in control T cells. More importantly, there
was no difference in the levels of CD4 expression between T cells
cultured with FePro labeled THP-1 cells and T cells cultured with
non-labeled THP-1 cells (Figure 6B). THP-1 induced down-
regulation of T cell surface CD8 expression was of less magnitude
compared to the THP-1 induced down-regulation of CD4.
However, the observed shift in expression was of the same pattern
in T cells cultured with FePro labeled THP-1 cells and T cells
cultured with non-labeled THP-1 cells (Figure 6B). MTT analysis
revealed that THP-1 induced allogenic T lymphocyte proliferation
was comparable in T cells co-cultured with non-labeled THP-1
cells and T cells co-cultured with FePro labeled THP-1 cells. Both
groups exhibited significant increase in formazen production
(MTT assay product) at day 7 of culture, with no significant
difference between groups (Figure 7). These data indicate that
FePro labeling did not affect the ability of THP-1 cells to stimulate
proliferation in allogeneic T cell.
Discussion
As immunologically active cells, through the activation of a
multitude of signaling pathways and complex interaction with the
other cell types, macrophages play a crucial role in both, the
adaptive and acquired immune responses and the ability to
respond to various stimuli is one of the major prerequisites for this
physiological role of macrophage type cells. In the present study,
we show that magnetic labeling with SPIO agent Ferumoxides-
Protamine Sulfate (FePro) does not alter major immunological
properties of macrophage-like THP-1 cells. As shown, THP-1 cells
labeled with FePro method exhibited abundant uptake of iron and
it has been postulated that this ferumoxides nanoparticles uptake
in macrophages may be mediated via the scavenger receptor SR-A
mediated endocytosis [25]. The present findings indicate that
endocytosed FePro nanoparticles do not alter the ability of THP-1
Figure 4. Effect of FePro labeling on THP-1 cell ability to respond to LPS stimulation. Effect of LPS on the levels of CD83 and CD54 cell
surface expression (A), TNF-a production (B) and activation of NFkB signaling pathway (C) in non-labeled and Fe-labeled THP-1 cells. (A) After
incubation with LPS, cells were stained with PE conjugated anti-CD54 and anti-CD83 antibodies. Flow cytometric histograms of the non treated
(control) cells (solid green lines), TPA treated (solid blue lines) and TPA and LPS treated (solid yellow lines) from one representative experiment are
shown (n=3). At least 10,000 live-gated cells were analyzed for PE expression. Isotype control shown as solid blue histograms. (B) TNF-a protein
levels in THP-1 cells supernatants after 4 h of stimulation with 100 ng/ml of LPS, determined by ELISA. Data expressed as means6SD. * p,0.05
compared to non-labeled, TPA differentiated and LPS stimulated control cells whose maximum response was set to be 100%. (C) Images of Western
blots of nuclear protein fraction probed with anti- p65NFkB antibody (top panel) and cytoplasmic protein fraction probed with anti-IkBa antibody
(lower panel). The data depicts the levels of protein in non-labeled and FePro labeled THP-1 cells after 24 h incubation with 100 nM of TPA and
following 30 minutes with 100 ng/ml of LPS. Single representative experiment is shown (n=3). The same patterns of relative NFkB and IkBa
expression were observed in all three experiments.
doi:10.1371/journal.pone.0002499.g004
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a differentiating agent TPA resulted in the expected changes in cell
morphology as well as in increase in the cell surface expression of
CD11b, CD117, CD86 and HLA-DR markers. Integrin a-M
(CD11b), a protein subunit of the heterodimeric integrin aMb2
complex expressed on the surface of cells involved in innate
immunity [26], has been shown to play an important role in
leukocyte activation, adhesion, migration and phagocytosis [27].
Stem cell factor receptor or c-KIT (CD117), a receptor tyrosine
kinase type III, has been described to play a role in cell survival,
proliferation and differentiation [28]. CD86, co-stimulatory
protein necessary for activation and priming of T cells, has been
reported to be expressed at low levels by monocytes and this
expression is increased upon cell activation [29,30]. Human
Leukocyte Antigen DR (HLA-DR), a major histocompatibility
complex class II receptor with the primary role of presenting
(foreign) peptide antigens to the immune system, has also been
described to be commonly expressed in macrophages [31]. Equal
response to TPA in non labeled and FePro labeled THP-1 cells
with regard to the expression of these cell surface molecules
indicates that labeled cells preserved their capacity to differentiate
into immunologically competent cells.
One of the pivotal roles of these immunologically active cells is
to combat infection/injury with an immediate, non-specific
reaction. Macrophages play a crucial role in this response by
migrating towards the source of stimulation and by releasing
cytokines that will further modulate the immunological response.
As mentioned earlier, one of the stimuli that play a role as
macrophage activator and that is released during Gram-negative
bacterial infections is LPS. The pro-inflammatory response to LPS
of macrophage like cells was characterized by an increase in TNF-
a secretion and CD 54 and CD 83 cell surface expression, and is
partially mediated by NFkB cell signaling pathway [17].
Intracellular Adhesion Molecule One (ICAM-1 or CD54) was
previously shown to be up-regulated in response to a variety of
inflammatory factors and to play a role in leukocyte migration and
T cell activation [24]. CD83 is expressed by mature dendritic cells
(DCs) as well as in DCs that were in vitro derived from monocytes
[32], and it is also postulated to play a role in activation of T-cells
[33]. Here, we show that FePro labeling did not affect THP-1 cells
ability to upregulate CD54 and CD83 in response to LPS. In
addition, increase in THP-1 cell’s TNF-a expression in response to
LPS stimulation was also not affected by FePro uptake. The
observed preserved ability of iron labeled THP-1 cells to secrete
TNF-a in response to LPS contrasted the results reported by
Siglienti et al., that indicated the inhibitory effect of iron uptake on
TNF-a production in LPS stimulated, iron labeled, rodent resident
peritoneal macrophages [34]. Since previous work by different
groups showed that resident macrophages isolated from rodent
peritoneal cavity release minimal amounts of TNF-a in response
to LPS-stimulation [35,36], it is possible that this discrepancy is
due to differences in the species and the type of cells used in the
studies. Interestingly, western blot analysis of nuclear p65 NFkB
and cytoplasmic IkB levels showed that THP-1 intracellular FePro
incorporation may cause this pathway to be up-regulated. Previous
studies have shown that cells labeled with iron oxide nanoparticles
complexed to cationic transfection agent exhibited transient
increase in reactive oxygen species (ROS) [10]. In addition,
Figure 5. Effect of FePro labeling on THP-1 cell chemotaxis in response to MCP-1 and Rantes. THP-1 cells incubated in the presence of
MCP-1 (A) and Rantes (B). Cell migration determined by fluorescence based assay, values expressed as units of fluorescence. Experiment included
non-labeled and FePro labeled THP-1 cells incubated without the treatment (white bars), incubated in the presence of 10% FBS (grey bars) and
300 ng/ml of MCP-1 or 50 ng/ml of Rantes (black bars). Bars, means6SD. * p,0.05 compared to non-labeled control cells.
doi:10.1371/journal.pone.0002499.g005
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activate NFkB pathway as well as increase the expression of NFkB
p65 subunit [37,38]. However, no difference in the levels of TNF-
a secretion and CD54 and CD83 cell surface expression between
FePro labeled and non labeled THP-1 cells indicated that the
observed slightly higher nuclear p65 NFkB protein levels
(accompanied with expected changes in the cytoplasmic IkB
levels) in FePro labeled THP-1 cells did not have significant effect
at the level of protein expression.
Another important property of macrophage cell type is the
ability to migrate along the concentration gradient of various
biomolecules. This chemotactic ability is necessary for the in vivo
regulation and control of inflammation. Rantes and MCP-1 are
molecules that belong to the C-C class of the beta chemokine
supergene family and are implicated to play a central role in
regulating acute as well as chronic inflammatory processes by
mediating the migration of mononuclear and polymorphonuclear
leukocytes [39,40]. Experiments presented here showed differen-
tial response of FePro labeled THP-1 cells towards MCP-1, Rantes
and serum proteins. Overall decrease in chemotaxis towards
MCP-1 and serum proteins indicate possible nonspecific effect of
the iron load on the ability of THP-1 cells to migrate. However,
the same effect was not observed when THP-1 cells were
incubated in the presence of Rantes, i.e no difference was
observed between the migration of FePro labeled and non-labeled
THP-1 cells. Previous studies done on Rantes and other
chemokines indicated that mononuclear and other cells express
promiscuous receptors that recognize one or more chemokine
within the beta family and this phenomenon maybe influenced by
differences in the binding affinities between different receptors and
chemokines [41,42]. It is possible that mechanisms of the observed
FePro effect on THP-1 chemotaxis involve changes in the
expression and/or function of chemokine receptors. However, to
further evaluate the implication of the observed altered THP-1
chemotaxis on the clinical application of FePro labeling, more
complex experimental design that would include the sequential
blockage of the receptors under the investigation is warranted.
Nevertheless, the in vitro set up presented here provided the general
insight on the existence of chemokine dependent, differential effect
of FePro nanoparticles on THP-1 cell chemotaxis.
In addition to their important role in innate immunity,
macrophages play a role in adaptive immunity [43] and one of
the aspects of this function is modulation and interaction with T
cells. Data presented here show that THP-1 cells co-cultured with
T cells induced a decrease in T cell expression of CD4 or CD8 cell
surface markers that define helper and cytotoxic T cell population,
respectively. The ability of THP-1 cells to down-regulate CD4 and
CD8 on T cells was not affected by FePro labeling. CD4 and CD8
play a role as T cell receptor co-receptors (TCR) that ensure the
binding specificity of TCR for a specific antigen and enhance the
signal initiated through TCR complex. The concrete mechanisms
of CD4 and CD8 downregulation have not been described before.
It has been previously shown that macrophages may be involved in
CD4+ T helper cell depletion [44]. However, the observed
downregulation may also involve IL-1 and/or INF-c mediated
effects [45,46]. Another aspect of macrophage interaction with T
cells is antigenic presentation and T cell activation and one of the
features of this interaction is induction of T cell proliferation. Here
we show that T cells proliferative activity in response to THP-1
cells was not affected by FePro labeling of THP-1 cells. This data
indicate that iron labeling may not have negative effect on
macrophage role as antigen presenting cells.
With further development of cell transplantation based imaging
techniques and correlated iron oxide cell labeling techniques it is
of utmost importance to ensure for minimal side effects that may
be caused by macrophage mediated in vivo clearance of
administered iron. The data presented here, generated from an
in vitro experimental set up, give the general insight into the
possible effects of intracellular FePro accumulation. However, it is
important to emphasize that under the in vivo conditions
immunological processes are the result of complex interplay
among tissue resident immune cells, cells recruited from
circulation, cytokines and other molecules generated in the course
Figure 6. Effect of FePro labeling on THP-1 cell ability to
modulate T cells. The data depicts the levels of CD markers
expression after 24 h of THP-1 cell-T cell co-culture. T cells were
stained with FITC conjugated anti-CD3, PE/Cy5 conjugated CD4 and PE
conjugated anti-CD8. Cells were gated based on the forward and side
scatter characteristics (R1) and on the expression of CD3 marker (R2)
(A). Flow cytometric histograms of T cells cultured without the
presence of THP-1 cells (red line), T cells co-cultured with non-labeled
THP-1 cells (blue line) and T cells co-cultured with FePro labeled THP-1
cells (green line) from representative experiment are shown. THP-1 cells
induced modulation of T cell expression levels of CD4 and CD8 (B).
Note the complete overlap of blue and green lines. At least 10,000 live-
gated cells were analyzed for CD4 and CD8 expression.
doi:10.1371/journal.pone.0002499.g006
Figure 7. Effect of FePro labeling on THP-1 ability to induce T
cell proliferation. Non-labeled and FePro labeled, gamma irradiated,
THP-1 cells co-cultured with T cells for 7 days. MTT proliferation assay
performed at day 3 (gray bars) and day 7 (black bars). Data are presented
as a mean6SD of values of optical density measured at 570 nm
wavelength. Statistical analysis was performed by comparing prolifer-
ation at day 7 with day 3 within the group (labeled or non-labeled THP-1
co-culture and labeled or non-labeled THP-1 cells only or T cells only)
and by comparing proliferation at day 7 between the groups (labeled vs.
non-labeled THP-1 co-culture). *=p,0.05 day 7 compared to day 3. No
significant difference was observed between labeled and non-labeled
conditions in co-culture and in THP-1 cells only samples.
doi:10.1371/journal.pone.0002499.g007
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FePro on macrophage modulatory role may necessitate an in vivo
set up that would enable the analysis of the ability of immune
system to respond to different pathological challenges. In
summary, by utilizing THP-1 cell line as a model for macrophage
cell type and by measuring a variety of endpoints (cell
differentiation, cell surface marker expression, cytokine produc-
tion, chemotaxis and immunological modulation) we demonstrat-
ed that endocytosed FePro nanoparticles did not significantly
affect immunological properties of THP-1 cells.
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